TSPO-PET-measurable neuroinflammation associates with brain atrophy in multiple sclerosis
Abhijith Yenikekaluva(Turku University Hospital), Laura Airas(Turku University Hospital), Maija Saraste(Turku University Hospital), Markus Matilainen(Turku University Hospital), Tanja Sjöros(Turku University Hospital), B Alfaifi(Jouf University), Rainer Hinz(University of Manchester), Juha Rinne(Turku University Hospital), Anniina Snellman(Turku University Hospital)
Cited by 0
Related Papers
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Effects of pre‐analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration
|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2021|128
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
|Journal of Internal Medicine|2021|105
The role of microglia in multiple sclerosis: implications for treatment with Bruton’s tyrosine kinase inhibitors
|Frontiers in Immunology|2025|17
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
|Frontiers in Immunology|2022|11